| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.25 | 8e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |